Virginia Lockatell

1.8k total citations
27 papers, 1.5k citations indexed

About

Virginia Lockatell is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Virginia Lockatell has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Virginia Lockatell's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), IL-33, ST2, and ILC Pathways (10 papers) and Eosinophilic Esophagitis (7 papers). Virginia Lockatell is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), IL-33, ST2, and ILC Pathways (10 papers) and Eosinophilic Esophagitis (7 papers). Virginia Lockatell collaborates with scholars based in United States, United Kingdom and France. Virginia Lockatell's co-authors include Harry L. T. Mobley, Sergei P. Atamas, David E. Johnson, Nevins W. Todd, Irina G. Luzina, J. Richard Hebel, Nereus W. Gunther, Phillip Kang, Alejandro De Las Peñas and Irene Castaño and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Virginia Lockatell

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia Lockatell United States 19 437 429 413 355 246 27 1.5k
Manuel Santamarı́a Spain 25 269 0.6× 325 0.8× 606 1.5× 255 0.7× 120 0.5× 100 1.9k
Amanda Welin Sweden 26 646 1.5× 379 0.9× 802 1.9× 352 1.0× 73 0.3× 56 1.7k
Ajitha Thanabalasuriar Canada 17 628 1.4× 200 0.5× 1.0k 2.4× 246 0.7× 231 0.9× 24 1.9k
R L Friedman United States 22 551 1.3× 233 0.5× 195 0.5× 237 0.7× 237 1.0× 39 1.4k
Philippe Dje N’Guessan Germany 23 696 1.6× 306 0.7× 707 1.7× 214 0.6× 138 0.6× 35 1.6k
Ravinder Singh India 16 749 1.7× 195 0.5× 446 1.1× 237 0.7× 65 0.3× 35 1.5k
J Parkkinen Finland 21 744 1.7× 367 0.9× 258 0.6× 761 2.1× 79 0.3× 29 2.0k
Henry Beekhuizen Netherlands 22 392 0.9× 281 0.7× 533 1.3× 120 0.3× 70 0.3× 37 1.5k
Janine Zahlten Germany 20 490 1.1× 287 0.7× 471 1.1× 132 0.4× 113 0.5× 32 1.2k
Dat P. Mao United States 8 1.9k 4.2× 241 0.6× 1.2k 2.8× 230 0.6× 112 0.5× 8 2.4k

Countries citing papers authored by Virginia Lockatell

Since Specialization
Citations

This map shows the geographic impact of Virginia Lockatell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Lockatell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Lockatell more than expected).

Fields of papers citing papers by Virginia Lockatell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Lockatell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Lockatell. The network helps show where Virginia Lockatell may publish in the future.

Co-authorship network of co-authors of Virginia Lockatell

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Lockatell. A scholar is included among the top collaborators of Virginia Lockatell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Lockatell. Virginia Lockatell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atamas, Sergei P., Virginia Lockatell, Nevins W. Todd, et al.. (2024). Therapeutic targeting of full-length interleukin-33 protein levels with cell-permeable decoy peptides attenuates fibrosis in the bleomycin model in vivo. Journal of Pharmacology and Experimental Therapeutics. 392(1). 100008–100008. 1 indexed citations
2.
Luzina, Irina G., Virginia Lockatell, Rita Fishelevich, et al.. (2022). Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashion. Cellular Immunology. 383. 104657–104657. 6 indexed citations
3.
Luzina, Irina G., Violeta Rus, Virginia Lockatell, et al.. (2021). Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects Against Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 66(2). 146–157. 12 indexed citations
4.
Luzina, Irina G., Erik P. Lillehoj, Virginia Lockatell, et al.. (2020). Therapeutic Effect of Neuraminidase-1–Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 376(1). 136–146. 25 indexed citations
5.
Luzina, Irina G., Rita Fishelevich, Brian Hampton, et al.. (2020). Full-length IL-33 regulates Smad3 phosphorylation and gene transcription in a distinctive AP2-dependent manner. Cellular Immunology. 357. 104203–104203. 8 indexed citations
6.
7.
Fishelevich, Rita, Virginia Lockatell, Brian Hampton, et al.. (2017). The full-length interleukin-33 (FLIL33)–importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation. Journal of Biological Chemistry. 292(52). 21653–21661. 17 indexed citations
8.
Luzina, Irina G., et al.. (2015). Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 355(1). 13–22. 14 indexed citations
9.
Lockatell, Virginia, Edward M. Pickering, Ronald E. Haskell, et al.. (2014). IFN-γ Directly Controls IL-33 Protein Level through a STAT1- and LMP2-dependent Mechanism. Journal of Biological Chemistry. 289(17). 11829–11843. 36 indexed citations
10.
Luzina, Irina G., Virginia Lockatell, Phillip Kang, et al.. (2013). Interleukin-33 Potentiates Bleomycin-Induced Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 49(6). 999–1008. 106 indexed citations
11.
Luzina, Irina G., Virginia Lockatell, Edward M. Pickering, et al.. (2012). Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma. Cytokine. 58(1). 20–26. 19 indexed citations
12.
Luzina, Irina G., Edward M. Pickering, Phillip Kang, et al.. (2012). Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion. The Journal of Immunology. 189(1). 403–410. 91 indexed citations
13.
Luzina, Irina G., Virginia Lockatell, Nevins W. Todd, et al.. (2011). Alternatively spliced variants of interleukin-4 promote inflammation differentially. Journal of Leukocyte Biology. 89(5). 763–770. 23 indexed citations
14.
Luzina, Irina G., Virginia Lockatell, Nevins W. Todd, et al.. (2011). Splice isoforms of human interleukin-4 are functionally active in mice in vivo. Immunology. 132(3). 385–393. 20 indexed citations
15.
Luzina, Irina G., Nevins W. Todd, Virginia Lockatell, et al.. (2009). Regulation of pulmonary inflammation and fibrosis through expression of integrins αVβ3 and αVβ5 on pulmonary T lymphocytes. Arthritis & Rheumatism. 60(5). 1530–1539. 66 indexed citations
16.
Luzina, Irina G., et al.. (2008). Macrophages Produce TGF-β-Induced (β-ig-h3) following Ingestion of Apoptotic Cells and Regulate MMP14 Levels and Collagen Turnover in Fibroblasts. The Journal of Immunology. 180(7). 5036–5044. 86 indexed citations
17.
Luzina, Irina G., et al.. (2007). Complex Regulation of Pulmonary Inflammation and Fibrosis by CCL18. American Journal Of Pathology. 171(2). 428–437. 61 indexed citations
18.
Castaño, Irene, Alejandro De Las Peñas, Margaret L. Zupancic, et al.. (2005). Nicotinic Acid Limitation Regulates Silencing of Candida Adhesins During UTI. Science. 308(5723). 866–870. 202 indexed citations
19.
Lane, M. Chelsea, et al.. (2005). Role of Motility in the Colonization of Uropathogenic Escherichia coli in the Urinary Tract. Infection and Immunity. 73(11). 7644–7656. 190 indexed citations
20.
Gunther, Nereus W., Virginia Lockatell, David E. Johnson, & Harry L. T. Mobley. (2001). In Vivo Dynamics of Type 1 Fimbria Regulation in Uropathogenic Escherichia coli during Experimental Urinary Tract Infection. Infection and Immunity. 69(5). 2838–2846. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Santamarı́a Breakdown of academic impact, for papers by Amanda Welin Breakdown of academic impact, for papers by Ajitha Thanabalasuriar Breakdown of academic impact, for papers by R L Friedman Breakdown of academic impact, for papers by Philippe Dje N’Guessan Breakdown of academic impact, for papers by Ravinder Singh Breakdown of academic impact, for papers by J Parkkinen Breakdown of academic impact, for papers by Henry Beekhuizen Breakdown of academic impact, for papers by Janine Zahlten Breakdown of academic impact, for papers by Dat P. Mao
Rankless by CCL
2026